here

 


 




UCSF Benioff Children's Hospital Oakland Blood & Marrow Transplantation Program is accredited by the Foundation for the Accreditation of Cellular Therapy (FACT). Patients with leukemia, lymphoma or other life-threatening disease or other blood disorders need the most effective care to improve and prolong their lives. FACT accreditation is the threshold for excellence in cellular therapy including bone marrow or cord blood transplant (BMT).
  
FACT-accredited organizations voluntarily seek and maintain FACT accreditation through a rigorous process, demonstrating their belief that patient needs are paramount. Receiving care from a cellular therapy organization within the prestigious community of FACT-accredited organizations can make you confident that you are in good hands. This accreditation applies to all services and facilities that were inspected by FACT, specifically pediatric allogeneic and autologous hematopoietic progenitor cell transplantation, marrow and peripheral blood cellular therapy product collection, and cellular therapy product processing with minimal manipulation.

This accreditation is based upon compliance with the most comprehensive standards in the field, verified by rigorous peer-reviewed inspections. A team of inspectors who are qualified by their degree of training and experience and that they perform cellular therapy functions in their daily practice carry out the on-site inspections. Accredited programs have the experience required to understand and provide for the unique needs of hematopoietic progenitor cell (HPC) transplant patients.
  • Medical Directors and program personnel meet FACT educational and experience requirements.
  • Clinical programs transplant a requisite number of patients annually.
  • Collection facilities perform a requisite number of cell collection procedures annually.
  • Cell transplantation is performed in accordance with policies for the safe administration of cells as required for optimum patient care.
  • Accredited programs utilize processes guided by quality management systems.
Review, approval, and training requirements ensure processes are appropriate and that personnel understand the duties required of them. The accreditation is effective for three years beginning March 31, 20015.

Accredited facilities are listed on the FACT website at www.factwebsite.org. In addition, the identities of accredited programs are published by FACT’s parent organizations, the American Society for Blood and Marrow Transplantation and the International Society for Cellular Therapy.
In This Section
Foundation for the Accreditation of Cellular Therapy (FACT)